

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Lazertinib mushonga mutsva wakanangana nekenza wakagadzirirwa kurapa mhando dzakasiyana dzekenza yemapapu. Mushonga uyu unotorwa nemuromo unoshanda nekudzivisa mapuroteni akasiyana anobatsira masero ekenza kukura nekupararira, uchipa tariro kuvarwere vane advanced non-small cell lung cancer (NSCLC) ine shanduko dzakasiyana dzemajini.
Kana iwe kana mumwe waunoda akanyorerwa lazertinib, unogona kunge uine mibvunzo yekuti inoshanda sei, zvekutarisira, uye kuitora sei zvakachengeteka. Ngatifambei nezvose zvaunoda kuziva nezvemushonga uyu wakakosha nenzira inoita seinodzoreka uye yakajeka.
Lazertinib mushonga wekurapa wakanangana uyo wekirasi yemishonga inonzi EGFR inhibitors. Yakagadzirirwa kunyanya kurapa masero ekenza yemapapu ane shanduko dzemajini dzakasiyana, kunyanya EGFR T790M mutation inogona kukura mushure mekurapwa nemimwe mishonga yekenza.
Funga nezve lazertinib sechishandiso chakarurama kwazvo chinonangana nenzvimbo dzakasiyana dzisina simba mumaseru ekenza. Kusiyana nechemotherapy yechinyakare inokanganisa masero akawanda akasiyana mumuviri wako, lazertinib inotarisa pamapuroteni akasiyana anopa simba kune yako chaiyo mhando yekenza. Iyi nzira yakanangana kazhinji inoreva mashoma migumisiro kana ichienzaniswa nekurapa kwakakura kwekenza.
Mushonga uyu unouya semapiritsi anotorwa nemuromo, zvinoreva kuti unogona kuutora kumba pane kuda kushanyira nzvimbo yekurapa kuti uwane infusions. Iyi nyore inogona kubatsira kuchengetedza hupenyu hwako hwehutano uchigamuchira kurapwa kwekenza kunoshanda.
Lazertinib inonyanya kushandiswa kurapa advanced non-small cell lung cancer (NSCLC) muvarwere vane tumor dzine EGFR mutations dzakasiyana. Chiremba wako achange aedza tishu yako yekenza kuti asimbise shanduko idzi dzemajini asati anyora mushonga uyu.
Mushonga uyu unowanzo nyorerwa kana kenza yako yapfuura mushure mekurapwa nemamwe maEGFR inhibitors akadai se erlotinib kana gefitinib. Inonyanya kushanda kurwisa T790M resistance mutation iyo inowanzoitika mumaseru ekenza yemumapapu nekufamba kwenguva.
Mune dzimwe nguva, lazertinib inogona kushandiswawo seyekutanga kurapa kenza yemumapapu ichangobva kuongororwa ine mamwe maEGFR mutations. Chiremba wako weoncologist achasarudza nguva yakanakisa zvichienderana nemaitiro ako ekenza uye hutano hwako hwese.
Lazertinib inoshanda nekudzivisa EGFR protein, iyo inomirira epidermal growth factor receptor. Iyi protein inowanzoita kuti maseru ane hutano akure uye aparadzane, asi mumaseru ekenza ane EGFR mutations, inova overactive uye inotyaira kukura kwetumor.
Kana lazertinib ikadzivisa iyi protein, inobvisa chiratidzo chikuru chekukura kwemaseru ekenza. Pasina chiratidzo ichi, maseru ekenza haakwanise kuwanda nekukurumidza uye anogona kutofa. Ichi ndicho chikonzero nei lazertinib ichionekwa se "targeted therapy" - inotarisa nzira chaiyo iyo kenza yako inoshandisa kukura.
Mushonga uyu unoonekwa se potent EGFR inhibitor, zvinoreva kuti inonyanya kushanda pakudzivisa protein kunyangwe mumaseru ekenza akagadzira kuramba kune mamwe mishonga yakafanana. Yakagadzirirwa kushanda kurwisa ese ari maviri ekutanga EGFR mutations uye kuramba mutations dzinogona kukura nekufamba kwenguva.
Tora lazertinib sezvinorayirwa nachiremba wako, kazhinji kamwe pazuva panguva imwechete zuva rega rega. Unogona kuitora uine kana pasina chikafu, asi edza kuenderana nehurongwa hwako kuti ikubatsire kuyeuka.
Medza piritsi rose negirazi remvura - usapwanye, utaune, kana kuputsa. Kana uine dambudziko rekumedza mapiritsi, taura nechikwata chako chehutano nezve nzira dzinogona kubatsira, asi usachinje piritsi pasina gwara ravo.
Haufaniri kutora lazertinib nemukaka kana kudzivisa zvimwe zvekudya, asi kazhinji zvakanaka kuchengeta chikafu chine hutano, chakaringana paunenge uri kurapwa kenza. Vamwe varwere vanowana kuti kutora nemukati mechikafu chidiki kunobatsira kudzivirira dumbu kusagadzikana, kunyangwe izvi zvisingadiwi.
Chengeta mushonga wako pakupisa kwemumba, kure nehunyoro nekupisa. Chengeta mumudziyo wayo wekutanga uye kure nevana nemhuka.
Kazhinji ucharamba uchitora lazertinib chero ichishanda nemazvo uye uchichigamuchira zvakanaka. Izvi zvinogona kuva mwedzi kana kunyange makore, zvichienderana nekuti kenza yako inopindura sei kurapwa.
Chiremba wako achatarisa kufambira mberi kwako kuburikidza nekuongorora nguva dzose uye bvunzo dzeropa kuti aongorore kuti mushonga uri kushanda sei. Vachatarisawo chero mhedzisiro inogona kuda kugadziriswa kwemadosi kana kuzorora kurapwa.
Kureba kwekurapwa kwakanyanya kuvanhu uye kunoenderana nezvinhu zvakaita sekuti kenza yako inopindura sei, hutano hwako hwese, uye kuti unogashira sei mushonga. Vamwe varwere vanotora lazertinib kwenguva yakareba vaine mhedzisiro yakanaka, nepo vamwe vachigona kuchinjira kune dzimwe nzira dzekurapa kana kenza yavo ichifambira mberi.
Usambomira kutora lazertinib usati wataurirana nachiremba wako weoncologist kutanga, kunyangwe uchinzwa zviri nani. Kurapwa kenza kunoda kutariswa kwakanyanya kwekurapa kuti uve nechokwadi chekubuda kwakanaka.
Kufanana nemishonga yese yekenza, lazertinib inogona kukonzera mhedzisiro, kunyangwe varwere vazhinji vachigamuchira zvakanaka. Mhedzisiro yakajairika inowanzo manejwa nekuchengetwa kwakakodzera uye kutariswa.
Heano mhedzisiro yaungasangana nayo, uye yeuka kuti kuva nemhedzisiro hakuite kuti mushonga usashande zvakanaka kwauri:
Izvi zvinowanzoitika zvinowanzoita zvishoma kusvika pakati nepakati uye zvinowanzoita nani muviri wako paunojaira mushonga. Chikwata chako chehutano chinogona kupa nzira dzakakosha dzekugadzirisa chimwe nechimwe chezviitiko izvi kana zvikaitika.
Zvimwe zvisingawanzoitiki asi zvakanyanya kukomba zvinogona kuitika, kunyangwe zvichishamisa. Izvi zvinosanganisira kuzvimba kwemapapu (pneumonitis), kuita kweganda kwakanyanya, matambudziko echiropa, uye shanduko dzemoyo. Chiremba wako achakutarisa zvakanyanya izvi kuburikidza nekutarisa nguva dzose uye bvunzo dzekurabhoritari.
Kana ukaona manyoka akanyanya, matambudziko ekufema, kuita kweganda kwakanyanya, kana chero zviratidzo zvinokunetsa, taura nechikwata chako chehutano nekukasira. Vanovapo kuti vakubatsire kugadzirisa chero matambudziko anomuka panguva yekurapa.
Lazertinib haikodzeri munhu wese, uye chiremba wako achanyatsoongorora kana zvakakunakira zvichibva munhoroondo yako yekurapa uye mamiriro ako ehutano azvino.
Haufanire kutora lazertinib kana uine allergy kwairi kana chero zvinhu zvayo. Chiremba wako achakuongorora iwe runyorwa rwakazara rwezvinhu kana iwe uchiziva zvirwere zvemishonga.
Vanhu vane mamwe mamiriro emoyo vangangoda kuongororwa kwakakosha kana vangave vasiri vakwikwidzi ve lazertinib, sezvo ichigona kukanganisa rhythm yemoyo. Chiremba wako anogona kuita EKG (moyo rhythm test) usati watanga kurapwa uye nguva nenguva panguva yekurapa.
Kana wakazvitakura kana uchiyamwisa, lazertinib haikurudzirwi nekuti inogona kukuvadza mwana ari kukura. Vakadzi vane makore ekubereka vana vanofanira kushandisa nzira dzekudzivirira kubata pamuviri dzinoshanda panguva yekurapwa uye kwemavhiki akati wandei mushure mekumisa mushonga.
Vanhu vane matambudziko makuru echiropa kana itsvo vangangoda kugadzirisa muyero kana vangave vasingakwanise kutora lazertinib zvakachengeteka. Chiremba wako achatarisa basa rechiropa chako neitsvo usati watanga kurapwa uye panguva yekurapwa.
Lazertinib inotengeswa pasi pezita rebrand Lazertinib mune dzimwe nyika, kunyangwe kuwanikwa kuchisiyana nedunhu. Mumisika mimwe, inogona kuwanikwa pasi pemazita akasiyana ebrand kana ichiri mumiedzo yekiriniki.
Mushonga uyu mutsva zvichienzaniswa nevamwe EGFR inhibitors, saka kuwanikwa kwayo kwekutengesa kuchiri kuwedzera pasi rose. Oncologist wako achaziva kana lazertinib iripo munzvimbo yako uye pasi pezita ripi.
Kana lazertinib isingawanikwi kwauri, chiremba wako anogona kukubatsira kuti uiwane kuburikidza nemiedzo yekiriniki kana zvirongwa zvakakosha. Usazeze kubvunza nezvezvose zvaunogona kusarudza.
Kana lazertinib isingawanikwi kana isina kukodzera kwauri, mamwe maEGFR inhibitors anogona kuva sarudzo. Izvi zvinosanganisira osimertinib (Tagrisso), iyo inowanzoonekwa seyakajairika yegoridhe yeT790M-positive lung cancer.
Zvimwe zvingasarudzwa zvinosanganisira erlotinib (Tarceva), gefitinib (Iressa), uye afatinib (Gilotrif), kunyangwe izvi zvinowanzo shandiswa mumamiriro akasiyana zvichienderana nekuchinja kwako kwakakosha kwegomarara uye nhoroondo yekurapa.
Oncologist wako achafunga nezvezvinhu zvakaita seprofile yako yegomarara, kurapwa kwakapfuura, hutano hwazvino, uye kuwanikwa kwemishonga paanokurudzira dzimwe nzira. Imwe neimwe yemishonga iyi ine mabhenefiti ayo uye profile yemigumisiro.
Dzimwe nguva mishonga yakasanganiswa kana mamwe marapirwo akatarwa angakurudzirwa panzvimbo pe, kana pamwe chete ne, EGFR inhibitors, zvichienderana nemamiriro ako ega.
Vose lazertinib uye osimertinib vanoshanda EGFR inhibitors, asi havasi nani kana kuipa kune mumwe nemumwe - ivo maturusi akasiyana ezvinhu zvakasiyana.
Osimertinib (Tagrisso) yanga iripo kwenguva refu uye ine data rakawanda rekiriniki rinotsigira kushandiswa kwayo. Inowanzoita sarudzo yekutanga yeT790M-positive kenza yemapapu uye yakaratidza mhedzisiro yakanaka mumiedzo yekiriniki.
Lazertinib itsva uye inogona kuve nezvimwe zvakanakira mune zvimwe zviitiko, kunyanya maererano nekukwanisa kwayo kuyambuka muuropi kurapa kenza yakapararira ikoko. Zvisinei, tsvakurudzo yakawanda inodiwa kuti ienzanise zvizere kushanda kwavo kwenguva refu.
Chiremba wako achasarudza pakati pemishonga iyi zvichienderana nezvinhu zvako zvekenza, kurapwa kwakapfuura, kuwanikwa, uye zvinhu zvako. Chinhu chakakosha ndechokuwana kurapwa kunoshanda zvakanakisisa mumamiriro ako chaiwo.
Lazertinib inogona kukanganisa rhythm yemoyo, saka vanhu vane mamiriro emoyo aripo vanoda kuongororwa nekuchenjerera uye kuongororwa. Chiremba wako anogona kuita EKG asati atanga kurapwa uye nguva nenguva panguva yekurapa kuti aongorore rhythm yemoyo wako.
Kana uine nhoroondo yematambudziko emoyo, izvi hazvikubvise otomatiki kubva pakutora lazertinib, asi zvinoreva kuti uchada kuongororwa zvakanyanya. Chikwata chako checardio-oncology chinogona kushanda pamwe chete kuti chive nechokwadi chekuti moyo wako unogara uine hutano panguva yekurapwa kwekenza.
Kana ukatora lazertinib yakawanda kupfuura yakarairwa netsaona, fonera chiremba wako kana nzvimbo yekudzora muchetura nekukasira. Usamirira kuti uone kana uchinzwa zvakanaka - zviri nani kuwana zano rechiremba nekukasira.
Kutora lazertinib yakawanda zvakanyanya kunogona kuwedzera njodzi yako yezvinetso zvakakomba, kunyanya matambudziko emoyo. Uya nebhodhoro remushonga wako newe kana uchida kutsvaga rubatsiro rwekurapa kuitira kuti vanopa hutano vazive chaizvo zvawakatora uye zvakawanda sei.
Kana ukakanganwa dose ye lazertinib, itore paunorangarira, kunze kwekunge yava nguva yekuenda kune yako inotevera dose. Muchiitiko ichocho, skip dose yakakanganwa uye tora yako inotevera dose panguva yakajairika.
Usambofa wakatora madosi maviri panguva imwe chete kuti ugadzirise dose yakakanganwa. Kana usina chokwadi nezvenguva, fonera chikwata chako chehutano kuti uwane gwara. Vanogona kukubatsira kuona nzira yakanakisa yekudzoka panguva yakachengeteka.
Unofanira kungomira kutora lazertinib kana chiremba wako akuudza. Izvi zvinowanzoitika kana kenza yako ichifambira mberi pasinei nekurapa, kana ukawana zvinetso zvakakomba, kana iwe nachiremba wako mukasarudza kuchinja kune imwe kurapwa.
Kunyange kana uchinzwa zvakanaka, usamira kutora lazertinib wega. Kurapa kenza kunoda mazinga emishonga anogara achishanda, uye kumira kamwe kamwe kunogona kubvumira kenza yako kukura nekukurumidza.
Nepo pasina hukama chaihwo pakati pe lazertinib nedoro, zviri nani kudzora kunwa doro panguva yekurapa kenza. Doro rinogona kuwedzera zvimwe zvinetso zvakadai sekuvhunduka uye kuneta, uye rinogona kukanganisa kugona kwechiropa chako kugadzirisa mishonga.
Kana ukasarudza kunwa dzimwe nguva, ita kudaro zvine mwero uye teerera kuti unonzwa sei. Taura nechikwata chako chehutano nezve zvakakodzera kune yako chaiyo mamiriro uye hutano hwese.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.